Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma

Item
http://www.wikidata.org/entity/Q34995745
Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesIncreased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapyIncreased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancerRadical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.Recent advances in the treatment of metastatic renal cell carcinoma.TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway.A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review.Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report.Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma.Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer.Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis.
P2860

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma

Item
http://www.wikidata.org/entity/Q34995745
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@ast
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@en
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@nl
type
label
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@ast
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@en
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@nl
prefLabel
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@ast
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@en
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Serum interferon alpha recepto ...... lear cell renal cell carcinoma
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932